Scienture Holdings, Inc. · NASDAQ:SCNX
Scienture — TRxADE HEALTH — Investor Presentation (March 2022)
16 slides from Scienture's investor presentation, Mar 28, 2022
Slide 1: Digitalizing the Retail Pharmacy Experience
Slide 2: Safe Harbor Statement
Safe Harbor Statement The information set forth herein contains forward-looking statements within the federal securities laws, ineluding the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to
Slide 3: About TRxADE HEALTH, INC.
About TRXADE HEALTH, INC. TRXADE HEALTH, INC. TRxADE is a technology-enabled health services platform company focused (NASDAQ:MEDS) on digitalizing the retail pharmacy experience by optimizing drug Share Price* $2.32 procurement, the prescription journey and patient engagement in the U.S. Market Cap
Slide 4: Divisions of TRxADE HEALTH
Divisions of TRxADE HEALTH Pharmaceutical Marketplaces (With Supporting B2B + Supporting Subsidiaries): Supplier-Pharmacy Marketplace Platform Communtry SPECIALTY Saeed PHARMACY Manufacturer-Distributor Marketplace Platform Rx Distributor 1) Pie slices not representative of revenue mix between subsi
Slide 5: TRxADE Marketplace
TRxADE Marketplace Independent Pharmacy and Clinics Our B2B Pharmaceutical Supply Chain Platform Footprint i j2 U.S. Pharmaceutical Industry’ Growth * Projected $685B per year industry size by 2023 and growing; Over 65,000 Opportunity pharmacy facilities * Approximately 9 out of 10 Americans live wi
Slide 6: TRxADE Marketplace: Trxade.com
TRxADE Marketplace < Trxade.com (Distributor Pharmaceutical Supply Chain Platform) Our Marketplace Solution: *TRxADE’s exchange platform offers a clear and concise interface that allows over 13,100+ registered members in 50 states to analyze “up- to-the-minute” supply & pricing from multiple pharma
Slide 7: TRxADE Marketplace: SOSRx.com
TRxXADE Marketplace SOSRx.com (Manufacturer Pharmaceutical Supply Chain Platform) Our Marketplace Solution: *The US Generic drug market reached $127.8 Billion in 2020." *A percentage of products become short dated, overstock or slow moving over time and become off contract *SOSRx marketplace is an i
Slide 8: TRxADE's Revenue Model
TRxADE’s Revenue Model TRxADE Platform An administrative fee of up to 6 percent of the buying price on generic pharmaceuticals and up to 1 percent on brand pharmaceuticals that pass through our platform. SOSRx An administrative fee of up to 20 percent paid by the manufacturer of the purchase’ price
Slide 9: Marketplace User Supporting Divisions
Marketplace User Supporting Divisions Ca Ue BONUM HEALTH Bonum Health Tele Health Company offers individual and Employer sponsored patients access to certified medical providers 24/7/365 in 50 states * Focus on uninsured and underinsured patients * Has Partnerships with 1,000+ Retail chain and indep
Slide 10: Selected Financials
10 Selected Financials * High Margin: Revenue from transaction fees on marketplace platform (Credit Card/PayPal model) does not include the drugs value (over $100M annually), hence “tech like margins” * Built-Out Platform: 13,100+ registered members with continued platform development requiring mini
Slide 11: Management
11 Management Suren Ajjarapu, Chairman of the Board and Chief Executive Officer Mr. Ajjarapu has served as Chairman of the Board, Chief Executive Officer and Secretary since our acquisition of Trxade Group, Inc., a Nevada corporation (“TRxADE Nevada”) (our predecessor company) on January 8, 2014, an
Slide 12: Key Takeaways
12 Key Takeaways NASDAQ:MEDS TRxADE is a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. A Tech Focused Healthcare Services Company Market Leader: Op
Slide 13: Contact Us
1183 Contact Us TRxADE HEALTH, INC. 2420 Brunello Trace Lutz , FL 34558 (800) 261-0281 www.trxadehealth.com @TRADE
Slide 14: Consolidated Balance Sheets
TRxADE HEALTH, INC. iv: Consolidated Balance Sheets p p e n l Xx . December 31, 2021 and 2020 December 31, December 31, | + d d | h 2021 2020 Consolidated Balance Sheet ase aaa Current Assets: Cash s 3,122,578 $ 5,919,578 Accounts Receivable, net 978,973 805,043 Inventory, 56,279 1,257,754 Prepaid A
Slide 15: Consolidated Statements of Operations
15 Appendix: Consolidated Statements of Operations TRxADE HEALTH, INC. Consolidated Statements of Operations Years Ended December 31, 2021 and 2020 2021 Revenues, net $ 9,889,433, Cost of Sales 5,143,468 Gross Profit 4,745,965 Operating Expenses Loss on Inventory Investment 1,226,426 Loss on Impairm
Slide 16: Reconciliation of Net Income to Adj. EBITDA
16 Appendix: Reconciliation of Net Income to Adj. EBITDA* Reconciliation of Net Income (Loss) attributable to TRxADE HEALTH, INC., to Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) and Adjusted EBITDA* Net loss attributable to TRxADE HEALTH, INC. Add (deduct): Interest, net